VR Adviser »

Vor Biopharma shares owned by VR Adviser

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by VR Adviser from 13F filings

Historical chart of VR Adviser investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by VR Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by VR Adviser

Quarter filed Position value Share count Share price at filing
2025-12-31 $25M 1.9M 13.08
2025-09-30 $24M 500k 48.72

More positions owned by VR Adviser

Apogee Therapeutics (APGE)
Oruka Therapeutics (ORKA)
Miragen Therapeutics (VRDN)
Spyre Therapeutics Com New (SYRE)
Kalvista Pharmaceuticals (KALV)
Ocular Therapeutix (OCUL)
Savara (SVRA)
Cogent Biosciences (COGT)
Erasca (ERAS)
Cytomx Therapeutics (CTMX)
Maze Therapeatics (MAZE)
Jade Biosciences Com New (JBIO)
Enliven Therapeutics (ELVN)
Oric Pharmaceuticals (ORIC)
Engene Holdings (ENGN)

View all positions for VR Adviser

Top funds holding Vor Biopharma

Fcpm Iii Services B.v.
Frazier Life Sciences Management
RA Capital Management
VR Adviser
Paradigm Biocapital Advisors
Dr. Jeffrey R. Jay, M.D.
Susquehanna International
Caligan Partners
Vanguard Group
BlackRock
Sphera Funds Management
Laurion Capital Management
UBS Group
FMR
Findell Capital Management

View all funds holding Vor Biopharma